BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18376471)

  • 1. [Complex influence of chemo- and ozonotherapy on the immunity of patients with destructive pulmonary tuberculosis].
    Platonova IL; Ivanov GA; Pisarenko Ei; Purskaia MB; Shchurko GV; Toporovich OI; Tkach EA; Pavlenko OV; Grechukha NR
    Probl Tuberk Bolezn Legk; 2008; (2):20-3. PubMed ID: 18376471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immune system in children with pulmonary tuberculosis].
    Elufimova VF; Mitinskaia LA; Romanova RIu; Abramova ZP
    Probl Tuberk; 1995; (1):13-5. PubMed ID: 7761370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quantitative, spectral, and serodiagnostic characteristics of antimycobacterial IgG, IgM, and IgA antibodies in patients with pulmonary tuberculosis].
    Avdienko VG; Babaian SS; Guseva AN; Kondratiuk NA; Rusakova LI; Averbakh MM; Gergert VIa
    Probl Tuberk Bolezn Legk; 2006; (10):47-55. PubMed ID: 17139833
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunological bases of tuberculin therapy in combined treatment of patients with pulmonary tuberculosis].
    Krylov VA; Gergert VIa; Korotkova ED; Pechaev MG; Kuz'mina NV; Baranova NI
    Probl Tuberk; 1994; (5):21-3. PubMed ID: 7870717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of complex treatment with tuberculin, splenin and antibacterial agents on the hemodynamic indices and immune state in patients with pulmonary tuberculosis].
    Bochkarev EG; Evstaf'ev IuA; Shcheglova VT
    Probl Tuberk; 1988; (2):38-42. PubMed ID: 3375216
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of tuberculin therapy on immunologic indicators in adolescents with pulmonary tuberculosis].
    Knoring BE; Pavlova MV; Ivanova LA
    Probl Tuberk; 1991; (12):31-4. PubMed ID: 1803370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [T- and b systems of immunity in patients with newly detected destructive pulmonary tuberculosis during complex therapy].
    Kogosova LS; Bal'tseva LV; Petrashenko AI
    Probl Tuberk; 1981 Feb; (2):24-8. PubMed ID: 6972527
    [No Abstract]   [Full Text] [Related]  

  • 8. [Specific features of cellular immunity of pulmonary tuberculosis in patients with diabetes mellitus].
    KarachunskiÄ­ MA; Gergert VIa; Iakovleva OB
    Probl Tuberk; 1997; (6):59-60. PubMed ID: 9503939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug-resistant pulmonary tuberculosis at the penitentiaries].
    Kononets AS
    Probl Tuberk Bolezn Legk; 2008; (12):60-3. PubMed ID: 19227326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunotherapy in the combined treatment of chronic destructive pulmonary tuberculosis].
    Ivanova LA
    Probl Tuberk; 1994; (3):16-9. PubMed ID: 7937662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of complex treatment in combination with short-wave therapy and protease inhibitors in first detected patients with pulmonary tuberculosis].
    Lomachenkov VD; Kuprikova IM; Golubeva VS; Pochtennyi IT; Nikolaeva GM
    Probl Tuberk; 1997; (1):42-4. PubMed ID: 9162925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of thymogen on the state of immunity in destructive pulmonary tuberculosis].
    Medus AI; Pisarevskaia LI; Nikishina EV
    Voen Med Zh; 1999 Oct; 320(10):65-7, 96. PubMed ID: 10605346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Specific and nonspecific immunity factors in pulmonary tuberculosis under chemo- and tuberculin therapy].
    Dzholdubaev YD
    Zdravookhr Kirg; 1980; (1):43-6. PubMed ID: 6103614
    [No Abstract]   [Full Text] [Related]  

  • 14. [Distribution of histocompatibility antigens in patients with pulmonary tuberculosis depending on disease course and immune response pattern].
    Knoring BE; Berkos AS; Sakharova IIa
    Probl Tuberk; 1995; (2):16-9. PubMed ID: 7777453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug sensitivity in Mycobacterium tuberculosis versus its viability, cytotoxicity, genotype, and the course of the process in patients with pulmonary tuberculosis].
    Manicheva OA; Lasunskaia EB; Zhuravlev VIu; Otten TF; Barnaulov AO; Mokrousov IV; Pavlova MV; VishnevskiÄ­ BI; Narvskaia OV
    Probl Tuberk Bolezn Legk; 2008; (12):18-22. PubMed ID: 19230183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Body reactivity in pulmonary tuberculosis patients who are alcoholics].
    Samtsov VS; Volosevich GV
    Probl Tuberk; 1981 May; (5):26-30. PubMed ID: 6973151
    [No Abstract]   [Full Text] [Related]  

  • 17. [Local ozone therapy in the complex surgical treatment of pulmonary and pleural tuberculosis patients].
    Dobkin VG; Sadovnikova SS; Kuz'min GP; Bondarev GB
    Probl Tuberk; 2001; (7):18-20. PubMed ID: 11763554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Secondary immunodeficiency and its myelopid correction in patients with infiltrative and disseminated pulmonary tuberculosis].
    Averchenkov VM; Lomachenkov VD; Fedotova NI; Meshkova RIa
    Probl Tuberk; 1998; (2):20-2. PubMed ID: 9613178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of lymphocyte subpopulations in a group of patients with tuberculosis unresponsive to antibiotic treatment.
    Giorgis GE; Galietti F; Miravalle C; Oliaro A; Onoscuri E; Onoscuri M
    Panminerva Med; 1988; 30(2):96-8. PubMed ID: 2971915
    [No Abstract]   [Full Text] [Related]  

  • 20. [The clinical and immunological manifestations of infiltrative pulmonary tuberculosis under natural zinc deficiency].
    Karzakova LM; Mokhireva LV; Elenkina ZhB; Suslikov VL
    Probl Tuberk Bolezn Legk; 2005; (6):36-9. PubMed ID: 16078720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.